Breaking News

House, Senate appropriators endorse NIH budget increase

January 28, 2026
Pharmalot Columnist, Senior Writer
Sebastien Bozon/AFP via Getty Images

STAT+ | Roche moves obesity drug to pivotal trials after mid-stage success

The company plans to start the Phase 3 studies this quarter after the drug, CT-388, led to substantial weight loss in a Phase 2 trial.

By Andrew Joseph


STAT+ | Trump administration proposes tiny pay raise to 2027 Medicare Advantage plans

New policy would further clamp down on insurers' coding practices

By Bob Herman


STAT+ | Newborn screening can save lives, but worries about potential harm slow adoption in the U.K.

U.K. government pressured to expand the list of screened diseases from 10 to closer to the dozens used in other countries. Advocates say lives are at stake.

By Andrew Joseph



More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Pharmalot? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.

No comments